Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.

Irish journal of medical science - 1 Aug 2023

O'Reilly David E, Dooley Lucy, Watson Geoffrey A, Clarke Roisin, Nolan Amy, Nolan Carmel, Berkeley Eileen, Farrell Michael, McDevitt Trudi, Rogers Melissa, Clabby Catherine, Gallagher David J

Abstract excerpt

INTRODUCTION: Predictive testing for BRCA1 or BRCA2 allows at-risk individuals to engage with appropriate screening and treatment services if a pathogenic mutation is identified. Previous studies have shown uptake of predictive testing to most commonly range between 20% and 40% (Table 2). This represents a missed cancer prevention opportunity. Possible explanations for this low uptake include lack of disclosure...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 36260241
DOI: 10.1007/s11845-022-03176-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.PMID 36260241Read ↗

Examining the uptake of predictive BRCA testing in the UK; findings and implicationsSemantic proximity Read ↗

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read ↗

Familial breast cancer genetic testing in the West of Ireland.Semantic proximity Read ↗

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland.Semantic proximity Read ↗

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.Semantic proximity Read ↗

"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.Semantic proximity Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

BRCA1/2 predictive testing: a study of uptake in two centres.Semantic proximity Read ↗

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.Semantic proximity Read ↗

Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.Semantic proximity Read ↗

Genetic testing in cancer: a systematic review of patient reported measuresSemantic proximity Read ↗

Information needs of women with BRCA mutations regarding cancer risk management and decision-making.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.